CRIS

Conviction 80HealthcareScan · Mon, Aug 10, 2026

CRIS$3.66-8.96%

ResistanceSupportVol 14

Vol MA14 85.97K

May 11May 28Jun 16Jul 6Jul 23Aug 10

CURIS INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.curis.com ↗

Price3.66

Change-8.96%

Gap-1.00%

Rel volume1.20×

Avg volume74.28K

Avg $ vol349.37K

SMA 204.69

SMA 502.70

SMA 2001.38

Price vs 50+35.70%

Price vs 200+165.06%

MA stackbullish

50/200 cross—

Supertrenddown · 5.40

RSI (14)44

MACD hist-0.27

MACD cross—

Stoch %K / %D7 / 12

ADX (14)39

+DI / −DI28 / 25

RSI divergenceBearish

MACD divergenceBearish

ATR %+14.77%

ADR %10.93%

52w high5.94

52w low0.2058

From 52w high-38.38%

Above 52w low+1678.43%

New 52w highNo

SqueezeOff

Bollinger width29.15%

%B-0.25

Donchian pos7.40%

Donchian high5.60

Donchian low3.51

AVWAP (52w high)4.96

vs AVWAP high-26.18%

AVWAP (52w low)0.3995

vs AVWAP low+816.22%

OBV trendFlat

Chaikin MF (20)-0.36

Today vs 20d1.20×

Avg vol (14d)85.97K

Avg vol (20d)74.28K

Avg $ vol (20d)349.37K

Market cap142.66M

RS 3m (vs SPY)+591.01%

RS 6m (vs SPY)+327.35%

RS line new highNo

Trend template7/8

Technical rank75.2

1 week-28.93%

1 month-26.21%

3 months+552.41%

6 months+255.34%

1 year+113.41%

YTD+272.33%

P/E-18.82

P/B11.23

P/S15.11

P/FCF-5.24

EPS-0.5800

Div yield—

ROE-59.67%

ROA-25.54%

Debt/Eq0.00

Current1.11

EV/EBITDA-22.85

Gross margin—

Net margin-80.29%

Rev growth-13.43%

EPS growth82.53%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value127.66M

Revenue0

Net income-24.2M

Gross profit—

Free cash flow-27.2M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out38.98M

Employees24

ListedTue, Aug 1, 2000

Free float12.66M

Float %92.2%

Short interest105.46K

Days to cover0.9d

Short volume63.4%

Squeeze score25 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank75.2 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.17

Support0.2606

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRIS

All disclosures →

No recent disclosed trades by Congress in CRIS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CRIS · 8 buys

Insider	Side	Shares	Value	Traded	Filed
GREENACRE MARTYN D Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
Borgman Anne Elizabeth Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
Dentzer James E President & CEO · Employee stock option (right to buy) · 2026-07-07	Grant	110.09K	$582K	2026-07-07	2026-07-09
Zung Jonathan B. CDO · Employee stock option (right to buy) · 2026-07-07	Grant	48.28K	$255K	2026-07-07	2026-07-09
Duvall Diantha CFO · Employee stock option (right to buy) · 2026-07-07	Grant	48.28K	$255K	2026-07-07	2026-07-09
Hohneker John Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
KAITIN KENNETH I Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
Rubin Marc Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09

SEC filings

EDGAR filings in CRIS · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.